Eledon Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELDN and other ETFs, options, and stocks.About ELDN
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential.
ELDN Key Statistics
Stock Snapshot
With a market cap of 193.34M, Eledon Pharmaceuticals(ELDN) trades at $2.58. The stock has a price-to-earnings ratio of -2.09.
During the trading session on 2026-03-05, Eledon Pharmaceuticals(ELDN) shares reached a daily high of $2.72 and a low of $2.52. At a current price of $2.58, the stock is +2.2% higher than the low and still -5.3% under the high.
Trading volume for Eledon Pharmaceuticals(ELDN) stock has reached 697.62K, versus its average volume of 980.9K.
Over the past 52 weeks, Eledon Pharmaceuticals(ELDN) stock has traded between a high of $4.60 and a low of $1.35.
Over the past 52 weeks, Eledon Pharmaceuticals(ELDN) stock has traded between a high of $4.60 and a low of $1.35.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.